Company Performance - Auna S.A. has returned 27.1% year-to-date, significantly outperforming the average gain of 5.4% for Medical stocks [4] - The Zacks Consensus Estimate for Auna S.A.'s full-year earnings has increased by 3.3% over the past quarter, indicating improved analyst sentiment and earnings outlook [3] Industry Context - Auna S.A. is part of the Medical Services industry, which consists of 59 individual stocks and currently ranks 139 in the Zacks Industry Rank. This industry has gained an average of 4.3% year-to-date, showing that Auna S.A. is performing better than its peers in this sector [5] - Another notable stock in the Medical sector is BioNTech SE Sponsored ADR, which has returned 7.8% year-to-date and belongs to the Medical - Biomedical and Genetics industry, currently ranked 62 with a year-to-date gain of 13.5% [4][6]

Analyst Background - The analyst is a Latin American economist with over 10 years of experience in investment management and company analysis, specializing in finding discounted stocks [4] - The analyst has worked as a Portfolio Manager at a large financial institution and previously in investment banking and economic journalism, with experience mainly in tech, retail, and banking [2] - The analyst holds an Economic BS and an MBA, and focuses on bottom-up analysis as well as macro-driven situations [2] Investment Approach - The analyst is a fundamentalist investor searching for discounted stocks across Latin America and worldwide [2] - The analyst believes there is still room for finding Alpha in many stocks and taking advantage of market overreactions [4] Disclosure - The analyst has a beneficial long position in the shares of AUNA through stock ownership, options, or other derivatives [3] - The analyst wrote the article themselves and expresses their own opinions, without receiving compensation other than from Seeking Alpha [3] - The analyst has no business relationship with any company whose stock is mentioned in the article [3]